12.00GBp0.00%Mkt Cap: 30.13M GBpP/E: —Last update: 2026-06-01
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturi…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap30.13M GBp
Enterprise Value49.25M GBp
Revenue (TTM)9.57M GBp
Gross Profit3.74M GBp
Net Income (TTM)-3.42M GBp
Revenue/Share0.0250 GBp
Last Price12.00 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees129
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)80.00
PEG—
EV/EBITDA-14.40
EV/Revenue5.15
P/S3.15
P/B8.00
EPS (TTM)-0.01
EPS (Forward)0.00
52W Range
0.000092% of range13.00
52W High13.00 GBp
52W Low0.0000 GBp
Profitability
Gross Margin44.32%
Oper. Margin-53.88%
EBITDA Margin-35.73%
Profit Margin-40.51%
ROE-64.43%
ROA-36.67%
Growth
Revenue Growth36.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.18M GBp
CapEx (TTM)346.00K GBp
FCF Margin-15.34%
FCF Yield-4.87%
Net Debt-2.76M GBp
Net Debt/EBITDA0.81
Balance Sheet
Debt/Equity0.19
Current Ratio1.91
Quick Ratio1.73
Book Value/Sh0.0150 GBp
Cash/Share0.0090 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)19.00 GBp
Target Range19.00 GBp – 19.00 GBp
# Analysts1
Ownership
Shares Out.251.08M
Float167.62M
Insiders30.84%
Institutions31.56%
Technical
SMA 509.690 (+23.8%)
SMA 2007.261 (+65.3%)
Beta0.12
S&P 52W Chg27.94%
Avg Vol (30d)583.87K
Avg Vol (10d)297.90K
Technical Indicators
RSI (14)61.9
MACD0.6309
MACD Signal0.7328
MACD Hist.-0.1018
BB Upper13.80 GBp
BB Middle11.59 GBp
BB Lower9.369 GBp
BB Width38.27%
ATR (14)1.534 GBp
Vol Ratio (20d)0.13x